The impairment of proteasome function is well documented in neurodegenerative diseases, while both the activation of TFEB/ALP and inactivation of TFEB/ALP has been reported in neurodegenerative diseases (Martini-Stoica et al., 2016; Finkbeiner, 2019). Here, TFEB is linked to neurodegenerative disease.